0001808220-21-000003.txt : 20210210 0001808220-21-000003.hdr.sgml : 20210210 20210210162009 ACCESSION NUMBER: 0001808220-21-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210209 ITEM INFORMATION: Other Events FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GoHealth, Inc. CENTRAL INDEX KEY: 0001808220 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39390 FILM NUMBER: 21614103 BUSINESS ADDRESS: STREET 1: 214 WEST HURON STREET CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: (312) 386-8222 MAIL ADDRESS: STREET 1: 214 WEST HURON STREET CITY: CHICAGO STATE: IL ZIP: 60654 8-K 1 goco-20210209.htm 8-K goco-20210209
FALSE000180822000018082202021-02-102021-02-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 9, 2021
_________________________
GoHealth, Inc.
(Exact name of registrant as specified in its charter)
_________________________
Delaware001-3939085-0563805
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
214 West Huron St.60654
Chicago,Illinois
(Address of principal executive offices)(Zip Code)
(312) 386-8200
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange
on which registered
Class A Common Stock,
$0.0001 par value per share		GOCOThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 8.01.    Other Events.
The Board of Directors of GoHealth, Inc. (the “Company”) has established May 26, 2021 as the date of the Company’s 2021 Annual Meeting of Stockholders (the “2021 Annual Meeting”). The 2021 Annual Meeting will be held virtually by means of remote communication. The details of the virtual annual meeting, including how stockholders can log into the virtual meeting, vote and submit questions, will be disclosed in the Company’s definitive proxy statement for the 2021 Annual Meeting to be filed with the Securities and Exchange Commission.
Any stockholder seeking to bring business before the 2021 Annual Meeting or to nominate a director must provide timely notice, as set forth in the Company’s Amended and Restated Bylaws (the “Bylaws”). Specifically, written notice of any proposed business or nomination must be received at the Company’s principal executive offices no later than February 20, 2021 (which is the tenth day following this public announcement of the date of the 2021 Annual Meeting). Any notice of proposed business or nomination must comply with the specific requirements set forth in the Bylaws.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GOHEALTH, INC.
Date:February 10, 2021By:/s/ Brian P. Farley
Brian P. Farley
Chief Legal Officer & Corporate Secretary

 EX-101.SCH 2 goco-20210209.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 goco-20210209_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 goco-20210209_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 goco-20210209_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Amendment Flag Amendment Flag Written Communications Written Communications City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 6 goco-20210209_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 goco-20210209_htm.xml IDEA: XBRL DOCUMENT 0001808220 2021-02-10 2021-02-10 false 0001808220 8-K 2021-02-09 GoHealth, Inc. DE 001-39390 85-0563805 214 West Huron St. 60654 Chicago, IL 312 386-8200 false false false false Class A Common Stock,$0.0001 par value per share GOCO NASDAQ true false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover
Feb. 10, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Feb. 09, 2021
Entity Registrant Name GoHealth, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39390
Entity Tax Identification Number 85-0563805
Entity Address, Address Line One 214 West Huron St.
Entity Address, City or Town Chicago,
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60654
City Area Code 312
Local Phone Number 386-8200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock,$0.0001 par value per share
Trading Symbol GOCO
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001808220
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.gohealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports goco-20210209.htm goco-20210209.xsd goco-20210209_cal.xml goco-20210209_def.xml goco-20210209_lab.xml goco-20210209_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true true JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "goco-20210209.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "goco-20210209_cal.xml" ] }, "definitionLink": { "local": [ "goco-20210209_def.xml" ] }, "inline": { "local": [ "goco-20210209.htm" ] }, "labelLink": { "local": [ "goco-20210209_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "goco-20210209_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "goco-20210209.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "goco", "nsuri": "http://www.gohealth.com/20210209", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "goco-20210209.htm", "contextRef": "i9b9dfaf7369a4bbc91e826d26748f1bf_D20210210-20210210", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.gohealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "goco-20210209.htm", "contextRef": "i9b9dfaf7369a4bbc91e826d26748f1bf_D20210210-20210210", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.gohealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 15 0001808220-21-000003-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001808220-21-000003-xbrl.zip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end